Clinical Trial: Low Dose Interferon Alpha Treatment for Oral Ulcers of Behcet's Disease

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Phase II Study, Evaluation of Low Dose Natural Human Interferon Alpha Administered by the Oral Mucosal Route in the Treatment of Behçet's Disease

Brief Summary: The purpose of this study is to determine the safety and efficacy of natural human interferon alpha (IFN alpha) on size, number, incidence and pain of oral ulcers associated with Behçet's Disease (BD).